Pharming Group to report third quarter 2024 financial results on October 24
10 Outubro 2024 - 3:00AM
Leiden, the Netherlands, October 10,
2024: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its
preliminary (unaudited) third quarter 2024 financial results, for
the period ended September 30, on Thursday, October 24,
2024.Pharming will host a presentation for analysts and investors
at 13:30 CEST/07:30 am EDT on October 24, 2024.
To participate in the conference call, please
register in advance using the link below. Once registered, dial-in
information and a unique PIN will be provided, allowing access to
the call.
Conference call
registration:Please note, the Company will only take
questions from dial-in attendees.
https://register.vevent.com/register/BId118ac68d9124f67b1a83e3769559100
To watch the live webcast, please register in
advance using the link below.
Webcast registration:
https://edge.media-server.com/mmc/p/yotjk8ib
About Pharming Group
N.V.Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq:
PHAR) is a global biopharmaceutical company dedicated to
transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules and biologics.
Pharming is headquartered in Leiden, the Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, the NetherlandsMichael
Levitan, VP Investor Relations & Corporate CommunicationsT: +1
(908) 705 1696E: investor@pharming.com
FTI Consulting, London, UKVictoria Foster
Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam,
the NetherlandsLeon MelensT: +31 6 53 81 64 27E:
pharming@lifespring.nl
- Pharming Group to report 3Q24 results_EN_10OCT24
Pharming Group NV (EU:PHARM)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Pharming Group NV (EU:PHARM)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
